Digital Content Evaluation and Analysis Platform License Subscription for CDC Office of Communication | SAM.gov Opportunity | G2X

Digital Content Evaluation and Analysis Platform License Subscription for CDC Office of Communication

Solicitation75D30126Q78839Notice typeCombined Synopsis/Solicitation, GA

Attachments

4 files

Name	Type	Posted	Actions
A19_SF30_Amendment 2.pdf	PDF	Mar 26, 2026	Download
A19_75D30126Q78839 Qustions and Answers_FInal.pdf	PDF	Mar 18, 2026	Download
A19_75D30126Q78843_Amendment 1.pdf	PDF	Mar 18, 2026	Download
A19_Solicitation_75D30126Q78839.pdf	PDF	Feb 26, 2026	Download

Version History

Digital Content Evaluation and Analysis Platform License Subscription for CDC Office of Communication

Combined Synopsis75D30126Q78839Mar 26, 2026 · v3

LatestViewing

Opportunity Summary

The Centers for Disease Control and Prevention (CDC) Office of Communication requires a license subscription for a digital evaluation and analysis platform to support usability testing of its digital content. This acquisition provides an online solution for conducting rapid remote user tests on desktop and mobile platforms, utilizing both unmoderated and moderated sessions with participants from a contributor network. The system must capture user screens, comments, and feedback, providing rapid transcriptions and results to allow staff to analyze data and improve the effectiveness of health communications across key audiences.

This federal opportunity is a combined synopsis/solicitation issued under solicitation number 75D30126Q78839. The procurement is classified under NAICS 518210 for Computing Infrastructure Providers, Data Processing, Web Hosting, and Related Services and PSC 7F20 for IT and Telecom - IT Management Tools/Products (Hardware and Perpetual License Software). The notice specifies a set-aside for the Small Business Administration (SBA). Primary performance will take place in Georgia, and the point of contact for this requirement is Jennifer Gartzke.

The deadline for response is March 30, 2026, at 12:00 PM EDT, as established by Amendment 2. The solicitation history includes four attachments: the initial solicitation posted on February 26, 2026; Amendment 1 and a Questions and Answers document posted on March 18, 2026; and Amendment 2 posted on March 26, 2026. These updates extended the quote submission deadline and incorporated technical clarifications for the procurement of the subscription services.

Generated by Lumen AI

Scoped analysis and attachments—go beyond the summary when you need detail from the solicitation package.

Opportunity Summary

Opportunity Details

Response deadline: Mar 30, 2026Expired 67 days ago
NAICS: 518210 (opens in new tab)
PSC: 7F20 (opens in new tab)
Set aside: SBA
Published: Feb 26, 2026
Updated: Mar 26, 2026
Agency: CENTERS FOR DISEASE CONTROL AND PREVENTION (opens in new tab)
Office: CENTERS FOR DISEASE CONTROL AND PREVENTION
Department: —
Source: View on SAM.gov (opens in new tab)

Contact and place of performance

Point of contact: Jennifer Gartzke

Place of performance

GA 30329

USA

Original Description

Amendment 2 is being issued to extend the due date for quotes. The new due date is Monday, March 30, 2026 and the time they're due is 12:00 PM EDT. No other changes are being made to the solicitation. Amendment 1 is being issued to upload the Q&A document and an amended copy of the solicitation. The due date has been moved to March 26, 2026 at 12:00 PM EDT. The purpose of this acquisition is to procure licens...